Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Maurizio Zangari

Concepts (495)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
148
2024
2934
10.290
Why?
Thalidomide
33
2016
374
3.020
Why?
Boronic Acids
17
2013
182
2.870
Why?
Pyrazines
17
2013
187
2.870
Why?
Hematopoietic Stem Cell Transplantation
22
2024
556
2.080
Why?
Bone Marrow
17
2022
356
1.930
Why?
Venous Thrombosis
8
2009
88
1.730
Why?
Antineoplastic Combined Chemotherapy Protocols
31
2024
1000
1.710
Why?
Paraproteinemias
7
2022
72
1.630
Why?
Angiogenesis Inhibitors
12
2009
182
1.560
Why?
Humans
162
2024
50201
1.400
Why?
Protease Inhibitors
7
2011
58
1.360
Why?
Chromosomes, Human, Pair 1
7
2023
92
1.330
Why?
Proteasome Inhibitors
6
2016
104
1.280
Why?
Prognosis
40
2024
1963
1.210
Why?
Antineoplastic Agents
20
2024
1176
1.190
Why?
Middle Aged
66
2024
12356
1.180
Why?
Alkaline Phosphatase
7
2020
94
1.170
Why?
Aged
63
2024
9505
1.170
Why?
Neoplasm, Residual
6
2022
160
1.140
Why?
Transplantation, Autologous
30
2024
463
1.120
Why?
Thrombosis
6
2013
249
1.060
Why?
Bone Remodeling
3
2016
149
1.050
Why?
Bone Diseases
2
2021
97
1.040
Why?
Antibodies, Bispecific
5
2024
71
1.010
Why?
Osteogenesis
4
2018
353
0.940
Why?
Male
73
2024
25572
0.940
Why?
Female
72
2024
26829
0.920
Why?
Immunologic Factors
5
2016
112
0.910
Why?
Gene Expression Profiling
21
2023
1029
0.890
Why?
Anticoagulants
6
2009
253
0.840
Why?
Peripheral Blood Stem Cell Transplantation
6
2012
53
0.840
Why?
Melphalan
12
2016
173
0.820
Why?
Neoplasms, Plasma Cell
4
2024
37
0.820
Why?
Activated Protein C Resistance
4
2011
10
0.790
Why?
Monoclonal Gammopathy of Undetermined Significance
8
2024
112
0.780
Why?
Parathyroid Hormone
4
2018
147
0.750
Why?
Venous Thromboembolism
3
2011
67
0.750
Why?
Antibodies, Monoclonal
4
2022
459
0.740
Why?
Adult
41
2024
13486
0.710
Why?
Durapatite
1
2020
24
0.700
Why?
Disease-Free Survival
21
2019
450
0.680
Why?
Gene Amplification
1
2019
57
0.670
Why?
Survival Rate
21
2020
906
0.670
Why?
Neoplasm Proteins
7
2020
321
0.670
Why?
Thromboembolism
3
2009
54
0.660
Why?
Dexamethasone
14
2024
434
0.660
Why?
Myeloablative Agonists
4
2012
30
0.650
Why?
Gene Expression Regulation, Neoplastic
12
2021
824
0.620
Why?
Bone and Bones
4
2021
477
0.620
Why?
Retrospective Studies
24
2024
6190
0.620
Why?
Factor V
4
2011
11
0.610
Why?
Spinal Fractures
1
2018
37
0.610
Why?
Aged, 80 and over
20
2024
3158
0.610
Why?
Oligopeptides
3
2018
95
0.610
Why?
Thymus Gland
1
2018
42
0.600
Why?
Stem Cell Transplantation
12
2024
179
0.590
Why?
Treatment Outcome
32
2024
5203
0.590
Why?
Parathyroidectomy
1
2018
46
0.590
Why?
Thyroidectomy
1
2018
59
0.580
Why?
Translocation, Genetic
8
2021
263
0.580
Why?
Disease Progression
16
2023
821
0.570
Why?
Clinical Trials as Topic
9
2022
468
0.570
Why?
Chromosome Aberrations
11
2023
295
0.560
Why?
Survival Analysis
14
2024
670
0.560
Why?
Calcification, Physiologic
1
2017
40
0.560
Why?
Follow-Up Studies
22
2024
2188
0.550
Why?
Risk Factors
23
2024
3644
0.550
Why?
Pelvis
1
2017
67
0.550
Why?
Osteoblasts
6
2020
451
0.540
Why?
Thrombophilia
4
2009
18
0.530
Why?
Tumor Microenvironment
5
2024
222
0.510
Why?
Chromosome Deletion
6
2023
140
0.490
Why?
Plasma Cells
9
2023
221
0.490
Why?
Drug Resistance, Neoplasm
7
2015
315
0.490
Why?
Neoplasms
3
2009
1233
0.480
Why?
B-Cell Maturation Antigen
6
2024
89
0.470
Why?
Animals
19
2024
13141
0.470
Why?
Transplantation Conditioning
7
2019
82
0.470
Why?
Receptor, Parathyroid Hormone, Type 1
1
2013
24
0.440
Why?
Neoplasm Recurrence, Local
7
2024
630
0.440
Why?
Polycythemia Vera
1
2013
6
0.430
Why?
Hemostasis
3
2008
56
0.420
Why?
Neovascularization, Pathologic
4
2009
153
0.420
Why?
Mutation
6
2022
1288
0.400
Why?
Combined Modality Therapy
17
2024
639
0.400
Why?
Neutropenia
2
2023
114
0.400
Why?
Hematopoietic Stem Cells
2
2012
182
0.370
Why?
Bone Neoplasms
2
2010
178
0.370
Why?
Amyloidosis
3
2009
78
0.360
Why?
Evolution, Molecular
2
2021
97
0.360
Why?
Doxorubicin
7
2009
234
0.350
Why?
Immunotherapy, Adoptive
4
2024
159
0.340
Why?
Mice
11
2024
5673
0.330
Why?
Anti-Anxiety Agents
1
2009
34
0.330
Why?
In Situ Hybridization, Fluorescence
7
2023
256
0.330
Why?
Kaplan-Meier Estimate
10
2019
463
0.330
Why?
Hemorrhagic Disorders
1
2009
5
0.320
Why?
Cryoglobulinemia
1
2008
12
0.320
Why?
Biopsy, Needle
1
2009
182
0.310
Why?
Pain
2
2009
373
0.310
Why?
Analgesics
1
2009
103
0.300
Why?
Recurrence
11
2024
660
0.300
Why?
Pulmonary Embolism
1
2009
97
0.300
Why?
Collagen
2
2020
208
0.300
Why?
Risk Assessment
7
2023
1255
0.300
Why?
Hematologic Neoplasms
2
2022
99
0.290
Why?
Cell Line, Tumor
4
2023
1390
0.280
Why?
Farnesyltranstransferase
1
2006
5
0.280
Why?
Vascular Endothelial Growth Factor Receptor-2
2
2004
30
0.280
Why?
Osteolysis
2
2022
75
0.270
Why?
Waldenstrom Macroglobulinemia
2
2022
40
0.270
Why?
Pyrroles
2
2004
68
0.270
Why?
Risk
4
2014
315
0.270
Why?
Cell Differentiation
4
2022
648
0.270
Why?
Neoplasms, Second Primary
2
2024
74
0.270
Why?
Cell Proliferation
8
2023
987
0.270
Why?
Sirolimus
1
2006
62
0.270
Why?
Time Factors
11
2021
2909
0.270
Why?
Logistic Models
5
2018
901
0.260
Why?
Signal Transduction
6
2021
1612
0.260
Why?
Chromosomes, Human, Pair 17
2
2017
36
0.250
Why?
Fluorodeoxyglucose F18
4
2021
190
0.240
Why?
Plasmacytoma
2
2020
40
0.240
Why?
Enoxaparin
1
2004
27
0.230
Why?
Polycomb Repressive Complex 2
2
2021
46
0.230
Why?
Remission Induction
10
2021
206
0.230
Why?
Indoles
2
2004
273
0.230
Why?
Vascular Endothelial Growth Factor A
2
2004
183
0.220
Why?
Prospective Studies
9
2019
2396
0.210
Why?
Blood Coagulation
1
2003
58
0.210
Why?
Positron-Emission Tomography
3
2022
288
0.210
Why?
Bone Resorption
2
2022
297
0.200
Why?
Immunoglobulin Light Chains
2
2017
82
0.200
Why?
Proto-Oncogene Proteins B-raf
2
2020
78
0.200
Why?
Hematopoietic Stem Cell Mobilization
3
2008
56
0.200
Why?
Randomized Controlled Trials as Topic
3
2012
553
0.200
Why?
Immunoconjugates
1
2022
38
0.200
Why?
Drug Approval
1
2022
47
0.200
Why?
Cell Cycle
2
2021
226
0.200
Why?
Hemorrhage
3
2009
196
0.200
Why?
Lymphoma, B-Cell
1
2022
61
0.190
Why?
Chromosomal Instability
2
2019
16
0.190
Why?
Epigenomics
1
2021
67
0.190
Why?
Chromosomes, Human, Pair 13
5
2008
38
0.190
Why?
Patient Participation
1
2022
67
0.190
Why?
SOXC Transcription Factors
1
2021
13
0.190
Why?
T-Lymphocytes
4
2024
329
0.190
Why?
Arkansas
5
2021
1988
0.180
Why?
Diffusion Magnetic Resonance Imaging
2
2019
125
0.180
Why?
Odontoblasts
1
2020
4
0.180
Why?
Calcium Phosphates
1
2020
5
0.180
Why?
HL-60 Cells
1
2020
18
0.180
Why?
U937 Cells
1
2020
14
0.180
Why?
Etoposide
5
2009
71
0.180
Why?
Kidney Diseases
2
2020
212
0.180
Why?
K562 Cells
1
2020
41
0.180
Why?
Genes, Tumor Suppressor
2
2021
73
0.180
Why?
NIH 3T3 Cells
1
2020
51
0.180
Why?
MCF-7 Cells
1
2020
62
0.180
Why?
Mammals
1
2020
57
0.180
Why?
Practice Guidelines as Topic
1
2023
459
0.170
Why?
Exosome Multienzyme Ribonuclease Complex
1
2020
12
0.170
Why?
Leukemia, Plasma Cell
1
2020
33
0.170
Why?
Protein C
2
2011
18
0.170
Why?
Myelodysplastic Syndromes
3
2007
79
0.170
Why?
beta 2-Microglobulin
5
2008
38
0.170
Why?
HEK293 Cells
1
2020
217
0.170
Why?
Cisplatin
6
2009
275
0.170
Why?
Busulfan
1
2019
19
0.170
Why?
Atrial Fibrillation
1
2022
182
0.170
Why?
HeLa Cells
1
2020
256
0.170
Why?
Gene Regulatory Networks
1
2020
107
0.170
Why?
Hematopoiesis, Extramedullary
1
2019
9
0.170
Why?
Epigenesis, Genetic
2
2020
371
0.160
Why?
Imaging, Three-Dimensional
2
2017
152
0.160
Why?
Genome-Wide Association Study
1
2020
163
0.160
Why?
Insulin-Like Growth Factor Binding Protein 2
1
2018
10
0.160
Why?
Healthcare Disparities
1
2022
279
0.160
Why?
Fractures, Compression
1
2018
17
0.160
Why?
Predictive Value of Tests
4
2009
921
0.160
Why?
Spleen
1
2019
170
0.150
Why?
Fibrinolysis
2
2009
5
0.150
Why?
Genomic Instability
2
2016
91
0.150
Why?
Phosphotransferases
1
2018
16
0.150
Why?
Blood Coagulation Factors
2
2009
17
0.150
Why?
Cytokines
3
2007
607
0.150
Why?
Antineoplastic Agents, Alkylating
6
2008
74
0.150
Why?
Bacteremia
1
2019
89
0.150
Why?
Adipocytes
1
2018
121
0.150
Why?
Cell Line
1
2020
1010
0.140
Why?
Gene Rearrangement
1
2018
73
0.140
Why?
Cluster Analysis
4
2012
233
0.140
Why?
Metaphase
4
2016
44
0.140
Why?
Hexokinase
1
2017
17
0.140
Why?
Heparin, Low-Molecular-Weight
2
2007
20
0.140
Why?
Ultrasonography, Doppler
2
2007
41
0.140
Why?
Renal Insufficiency
4
2010
108
0.130
Why?
Fibrinolytic Agents
2
2007
126
0.130
Why?
Clonal Evolution
1
2016
56
0.130
Why?
Calcium
1
2018
400
0.130
Why?
Gene Expression Regulation, Enzymologic
1
2017
178
0.130
Why?
Tumor Burden
3
2020
131
0.130
Why?
Gene Expression
1
2018
612
0.130
Why?
Disease Models, Animal
4
2016
1419
0.130
Why?
Tumor Suppressor Protein p53
1
2017
214
0.120
Why?
Immunotherapy
2
2016
235
0.120
Why?
Multivariate Analysis
7
2021
581
0.120
Why?
Genes, Neoplasm
1
2015
30
0.120
Why?
Bone Marrow Transplantation
4
2022
112
0.120
Why?
Polymorphism, Single Nucleotide
2
2020
484
0.120
Why?
Gene Dosage
1
2015
78
0.120
Why?
Salvage Therapy
6
2006
136
0.120
Why?
Incidence
2
2009
1000
0.120
Why?
Algorithms
1
2018
615
0.120
Why?
Osteoclasts
3
2022
424
0.110
Why?
Cystatin M
2
2024
19
0.110
Why?
Case-Control Studies
4
2011
1145
0.110
Why?
Altitude
1
2013
16
0.110
Why?
Chromosomes, Human, Pair 11
3
2020
54
0.110
Why?
Janus Kinase 2
1
2013
25
0.110
Why?
Cross-Sectional Studies
3
2023
1580
0.110
Why?
Tomography, X-Ray Computed
2
2017
1160
0.110
Why?
STAT3 Transcription Factor
2
2010
80
0.110
Why?
Models, Biological
1
2016
722
0.100
Why?
Bone Density Conservation Agents
2
2010
74
0.100
Why?
Protein-Tyrosine Kinases
3
2018
94
0.100
Why?
Mice, Inbred C57BL
1
2018
1782
0.100
Why?
Creatinine
2
2010
142
0.100
Why?
Cytogenetic Analysis
6
2014
80
0.100
Why?
Viremia
1
2012
22
0.100
Why?
Clone Cells
2
2023
78
0.100
Why?
Cytomegalovirus Infections
1
2012
34
0.100
Why?
Models, Genetic
2
2016
174
0.100
Why?
Clinical Trials, Phase II as Topic
1
2012
46
0.100
Why?
Clinical Trials, Phase III as Topic
1
2012
46
0.100
Why?
Viper Venoms
1
2011
7
0.100
Why?
Drug Evaluation, Preclinical
1
2012
145
0.090
Why?
Epidemiologic Methods
2
2008
49
0.090
Why?
NF-kappa B
2
2018
315
0.090
Why?
Receptors, TNF-Related Apoptosis-Inducing Ligand
1
2010
6
0.090
Why?
Arsenicals
1
2010
14
0.090
Why?
TNF-Related Apoptosis-Inducing Ligand
1
2010
20
0.090
Why?
Oxides
1
2010
18
0.090
Why?
Mutation Rate
2
2021
36
0.090
Why?
Granulocyte Colony-Stimulating Factor
2
2008
60
0.090
Why?
Hypercalcemia
1
2010
33
0.090
Why?
Transplantation, Homologous
4
2003
140
0.090
Why?
Cyclophosphamide
4
2003
164
0.090
Why?
Janus Kinase 1
1
2010
16
0.090
Why?
Anemia
1
2010
66
0.090
Why?
Antineoplastic Agents, Hormonal
2
2007
49
0.090
Why?
MAP Kinase Kinase 1
1
2010
23
0.090
Why?
Cyclin-Dependent Kinases
1
2010
26
0.090
Why?
Administration, Oral
2
2009
432
0.090
Why?
Proteinuria
1
2010
39
0.090
Why?
Alleles
2
2021
253
0.090
Why?
Extracellular Signal-Regulated MAP Kinases
1
2010
81
0.090
Why?
Genomics
2
2023
284
0.090
Why?
Diphosphonates
1
2010
90
0.080
Why?
Lorazepam
1
2009
12
0.080
Why?
Dose-Response Relationship, Drug
3
2008
1356
0.080
Why?
Receptors, Retinoic Acid
1
2009
22
0.080
Why?
Anesthesia, Local
1
2009
16
0.080
Why?
Oxycodone
1
2009
26
0.080
Why?
Hyperhomocysteinemia
1
2009
30
0.080
Why?
Prednisone
1
2009
101
0.080
Why?
Histones
2
2021
296
0.080
Why?
Tretinoin
1
2009
53
0.080
Why?
Hemostatic Techniques
1
2009
29
0.080
Why?
Plasma Exchange
1
2009
23
0.080
Why?
Vasculitis
1
2008
29
0.080
Why?
Vincristine
3
2003
85
0.080
Why?
Syndecan-1
3
2021
72
0.080
Why?
Transcription Factors
2
2023
563
0.080
Why?
Biopsy
3
2018
592
0.080
Why?
Drug Therapy, Combination
1
2009
382
0.080
Why?
Carrier Proteins
1
2010
302
0.080
Why?
DNA Copy Number Variations
2
2021
109
0.080
Why?
Bone Development
1
2009
64
0.080
Why?
Cytogenetics
1
2008
23
0.080
Why?
Radiopharmaceuticals
2
2021
205
0.080
Why?
Pain Measurement
1
2009
246
0.080
Why?
Platelet Aggregation
1
2008
71
0.080
Why?
Thrombocytopenia
1
2009
84
0.070
Why?
Staphylococcal Infections
2
2019
269
0.070
Why?
Double-Blind Method
1
2009
682
0.070
Why?
Brain Diseases, Metabolic
1
2007
5
0.070
Why?
Phlebography
1
2007
60
0.070
Why?
Hyperammonemia
1
2007
23
0.070
Why?
Myeloma Proteins
1
2007
24
0.070
Why?
Antimetabolites
1
2006
12
0.070
Why?
Cell Communication
2
2023
69
0.070
Why?
Chi-Square Distribution
1
2007
280
0.070
Why?
Transcriptome
2
2020
316
0.070
Why?
Partial Thromboplastin Time
1
2006
12
0.070
Why?
Magnetic Resonance Imaging
4
2007
1529
0.070
Why?
Osteoprotegerin
1
2006
52
0.070
Why?
Heterozygote
1
2006
82
0.070
Why?
Acetaminophen
1
2009
274
0.070
Why?
Antibiotics, Antineoplastic
1
2006
77
0.070
Why?
Gastrointestinal Neoplasms
1
2006
40
0.070
Why?
Models, Statistical
1
2007
225
0.060
Why?
Pilot Projects
1
2008
703
0.060
Why?
Age Factors
3
2005
1096
0.060
Why?
Femur Head Necrosis
1
2005
18
0.060
Why?
Neovascularization, Physiologic
1
2005
68
0.060
Why?
Apoptosis
1
2010
1093
0.060
Why?
Gene Deletion
2
2003
267
0.060
Why?
Syndrome
2
2019
239
0.060
Why?
Killer Cells, Natural
1
2024
107
0.060
Why?
Ferritins
1
2024
30
0.060
Why?
Demography
1
2024
93
0.060
Why?
Glucuronidase
1
2003
48
0.060
Why?
Myeloid Progenitor Cells
1
2023
17
0.060
Why?
X-Ray Microtomography
1
2024
78
0.060
Why?
CD8-Positive T-Lymphocytes
1
2024
123
0.060
Why?
DNA Methylation
2
2020
546
0.060
Why?
Receptors, G-Protein-Coupled
1
2024
54
0.060
Why?
Immunosuppressive Agents
1
2005
226
0.050
Why?
DNA, Neoplasm
2
2020
146
0.050
Why?
Antibodies
1
2024
151
0.050
Why?
Discitis
1
2003
9
0.050
Why?
Oligonucleotide Array Sequence Analysis
4
2006
409
0.050
Why?
Myeloproliferative Disorders
1
2003
26
0.050
Why?
Antigens, CD34
1
2003
65
0.050
Why?
TNF Receptor-Associated Factor 3
1
2022
13
0.050
Why?
Platelet Count
3
2008
74
0.050
Why?
Tumor Cells, Cultured
3
2010
462
0.050
Why?
Patients
1
2022
47
0.050
Why?
Rats
1
2009
3277
0.050
Why?
Geography
1
2022
61
0.050
Why?
Leukemia, Myeloid
1
2002
42
0.050
Why?
Myeloid Differentiation Factor 88
1
2022
33
0.050
Why?
Receptors, Antigen, T-Cell
1
2022
50
0.050
Why?
Drug Interactions
1
2002
208
0.050
Why?
Patient Selection
1
2023
254
0.050
Why?
Chromosome Disorders
1
2002
35
0.050
Why?
United States Food and Drug Administration
1
2022
91
0.050
Why?
Oncogenes
1
2021
57
0.050
Why?
Phylogeny
1
2022
234
0.050
Why?
Enzyme Inhibitors
1
2004
378
0.050
Why?
Hypothyroidism
1
2002
54
0.050
Why?
Central Nervous System Neoplasms
1
2002
64
0.050
Why?
RANK Ligand
1
2022
179
0.050
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2022
84
0.050
Why?
Cohort Studies
2
2020
1414
0.050
Why?
Transcriptional Activation
1
2021
121
0.050
Why?
Chromatin
1
2021
138
0.050
Why?
Lymphoma, Large B-Cell, Diffuse
1
2022
104
0.050
Why?
Antibodies, Monoclonal, Humanized
1
2022
224
0.050
Why?
Proto-Oncogene Proteins p21(ras)
1
2021
66
0.050
Why?
Cyclin D2
1
2020
20
0.050
Why?
Pyrimidines
1
2022
192
0.050
Why?
Aneuploidy
1
2020
18
0.040
Why?
Endothelium, Vascular
1
2002
252
0.040
Why?
Proto-Oncogene Proteins c-maf
1
2020
19
0.040
Why?
Chromosomes, Human, Pair 4
1
2020
31
0.040
Why?
Histone Code
1
2020
30
0.040
Why?
Gene Expression Regulation, Leukemic
1
2020
32
0.040
Why?
Genome, Human
1
2021
110
0.040
Why?
Cyclin D1
1
2020
56
0.040
Why?
ras Proteins
1
2020
64
0.040
Why?
Longitudinal Studies
2
2016
700
0.040
Why?
Protein Kinase Inhibitors
1
2022
205
0.040
Why?
Chromosomes, Human, Pair 14
1
2020
75
0.040
Why?
Transcriptional Elongation Factors
1
2020
17
0.040
Why?
Postoperative Complications
1
2007
1027
0.040
Why?
Genetic Loci
1
2020
44
0.040
Why?
Health Status Disparities
1
2022
196
0.040
Why?
RNA, Messenger
3
2010
1097
0.040
Why?
Genetic Variation
1
2020
215
0.040
Why?
DNA Mutational Analysis
1
2020
176
0.040
Why?
High-Throughput Nucleotide Sequencing
1
2020
168
0.040
Why?
Neoplastic Stem Cells
2
2015
100
0.040
Why?
Computational Biology
1
2020
214
0.040
Why?
Gram-Positive Bacterial Infections
1
2019
27
0.040
Why?
Pseudomonas Infections
1
2019
50
0.040
Why?
Proline
1
2018
30
0.040
Why?
Bone Marrow Cells
2
2014
190
0.040
Why?
DNA-Binding Proteins
1
2021
424
0.040
Why?
Recombinant Proteins
2
2010
480
0.040
Why?
Promoter Regions, Genetic
1
2020
466
0.040
Why?
Fluorescent Dyes
1
2018
105
0.040
Why?
Receptor Protein-Tyrosine Kinases
1
2018
51
0.040
Why?
Proteolysis
1
2018
96
0.040
Why?
Oncogene Proteins, Fusion
1
2018
59
0.040
Why?
Extracellular Matrix
1
2018
108
0.040
Why?
Kidney Function Tests
1
2017
49
0.040
Why?
Cell Movement
1
2018
245
0.040
Why?
False Positive Reactions
1
2017
62
0.040
Why?
Glomerular Filtration Rate
1
2017
111
0.030
Why?
Amino Acid Sequence
1
2018
576
0.030
Why?
Genetic Predisposition to Disease
1
2020
508
0.030
Why?
Cell Survival
2
2010
590
0.030
Why?
Genes, ras
1
2016
43
0.030
Why?
Genes, p53
1
2016
51
0.030
Why?
Mice, SCID
2
2009
173
0.030
Why?
Glycolysis
1
2016
68
0.030
Why?
Chromosome Mapping
2
2006
158
0.030
Why?
Image Interpretation, Computer-Assisted
1
2016
105
0.030
Why?
Phosphatidylinositol 3-Kinases
1
2016
139
0.030
Why?
Serum Albumin
2
2008
58
0.030
Why?
Syndecans
2
2006
34
0.030
Why?
Proteoglycans
2
2006
81
0.030
Why?
Drug Monitoring
1
2015
78
0.030
Why?
Cells, Cultured
1
2018
1587
0.030
Why?
Myocardium
1
2017
443
0.030
Why?
Interspersed Repetitive Sequences
1
2014
8
0.030
Why?
Karyotype
1
2014
17
0.030
Why?
Proportional Hazards Models
2
2006
408
0.030
Why?
Membrane Glycoproteins
2
2006
244
0.030
Why?
Transplantation Chimera
2
2003
15
0.030
Why?
Infusions, Intravenous
2
2003
213
0.030
Why?
Neoplasm Staging
2
2007
749
0.030
Why?
RNA Interference
1
2013
178
0.030
Why?
Cytomegalovirus
1
2012
27
0.030
Why?
Viral Load
1
2012
76
0.020
Why?
Virus Activation
1
2012
35
0.020
Why?
Graft vs Host Disease
2
2003
73
0.020
Why?
United States
1
2022
4898
0.020
Why?
Interferon Regulatory Factor-1
1
2010
14
0.020
Why?
Cell Growth Processes
1
2010
22
0.020
Why?
Antiviral Agents
1
2012
168
0.020
Why?
CDC2-CDC28 Kinases
1
2010
11
0.020
Why?
Femur
1
2010
132
0.020
Why?
Long-Term Care
1
2010
50
0.020
Why?
Peripheral Nervous System Diseases
1
2010
57
0.020
Why?
RNA, Small Interfering
1
2010
210
0.020
Why?
Down-Regulation
1
2010
342
0.020
Why?
Bone Diseases, Metabolic
1
2010
73
0.020
Why?
Cell Transformation, Neoplastic
1
2010
181
0.020
Why?
Abnormalities, Multiple
1
2010
167
0.020
Why?
Protein Isoforms
1
2009
118
0.020
Why?
Ploidies
1
2008
11
0.020
Why?
Ligands
1
2009
203
0.020
Why?
Polyethylene Glycols
1
2008
86
0.020
Why?
Rabbits
1
2009
376
0.020
Why?
Hemoglobins
1
2008
106
0.020
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2009
579
0.020
Why?
Age Distribution
1
2007
169
0.020
Why?
C-Reactive Protein
1
2008
143
0.020
Why?
Ammonia
1
2007
77
0.020
Why?
Diagnosis, Differential
1
2010
1041
0.020
Why?
Mass Screening
1
2010
348
0.020
Why?
Blood Proteins
1
2007
77
0.020
Why?
Multigene Family
1
2006
56
0.020
Why?
Brain
2
2007
1311
0.020
Why?
Cyclin D
1
2006
18
0.020
Why?
Bone Density
1
2009
386
0.020
Why?
Cyclins
1
2006
38
0.020
Why?
Evidence-Based Medicine
1
2007
247
0.020
Why?
RNA, Neoplasm
1
2006
45
0.020
Why?
Leukemia, Myeloid, Acute
1
2007
180
0.020
Why?
Radiography
1
2007
485
0.020
Why?
Coculture Techniques
1
2006
143
0.020
Why?
Data Interpretation, Statistical
1
2006
159
0.020
Why?
Neoplasms, Experimental
1
2006
111
0.020
Why?
Interferon-alpha
1
2005
49
0.020
Why?
Survivors
1
2006
120
0.020
Why?
Databases, Factual
1
2007
660
0.010
Why?
Mice, Transgenic
1
2006
542
0.010
Why?
Monosomy
1
2003
5
0.010
Why?
Odds Ratio
1
2005
548
0.010
Why?
Trisomy
1
2003
31
0.010
Why?
History, 21st Century
1
2003
56
0.010
Why?
Endothelial Growth Factors
1
2003
9
0.010
Why?
Vascular Endothelial Growth Factors
1
2003
13
0.010
Why?
Lymphokines
1
2003
20
0.010
Why?
Fusion Proteins, bcr-abl
1
2003
19
0.010
Why?
History, 20th Century
1
2003
95
0.010
Why?
Stem Cell Factor
1
2003
7
0.010
Why?
Confidence Intervals
1
2003
155
0.010
Why?
Probability
1
2003
164
0.010
Why?
Lymphocyte Transfusion
1
2003
10
0.010
Why?
Interphase
1
2003
13
0.010
Why?
Diploidy
1
2003
26
0.010
Why?
Leukocyte Count
1
2003
72
0.010
Why?
Back Pain
1
2003
38
0.010
Why?
Sex Factors
1
2005
700
0.010
Why?
Interferons
1
2002
38
0.010
Why?
Cell Count
1
2003
147
0.010
Why?
Intercellular Signaling Peptides and Proteins
1
2003
100
0.010
Why?
Drug Administration Schedule
1
2003
369
0.010
Why?
Thyroid Function Tests
1
2002
24
0.010
Why?
Thyrotropin
1
2002
47
0.010
Why?
Prevalence
1
2005
960
0.010
Why?
Tissue Donors
1
2003
111
0.010
Why?
Fatal Outcome
1
2002
195
0.010
Why?
Neutrophils
1
2003
148
0.010
Why?
Cell Division
1
2002
293
0.010
Why?
Reoperation
1
2003
454
0.010
Why?
Acute Disease
1
2002
368
0.010
Why?
Up-Regulation
1
2002
446
0.010
Why?
Anti-Bacterial Agents
1
2003
744
0.010
Why?
Zangari's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description